Most Recent Articles by Diana Ernst, RPh
Longhurst, Hilary, et al. "Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor"
A review of the studies cited in the ADA guidelines revealed "inconsistent and contradictory evidence" surrounding some of the recommendations.
The researchers searched the U.S. Medicare database for NVAF patients 65 years of age and older who were newly prescribed one of the following medications: apixaban, dabigatran, rivaroxaban, or warfarin.
Previous studies involving statins have shown both men and women having similar risk reduction in cardiovascular disease events for every 39mg/dL reduction in LDL-C.